Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CMPX
#2473
Compass Therapeutics, Inc. Common Stock
5.4
4
USD
+4.62%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+4.62%
Monthly Change
+3.62%
6 month change
+25.35%
Year Change
+225.75%
Previous Close
5.2
0
Open
5.4
4
Bid
Ask
Low
5.4
4
High
5.4
4
Volume
88
Markets
US Stock Market
Healthcare
CMPX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
52.11 M
101.3 M
126.51 M
137.59 M
138.28 M
180.09 M
—
Valuation ratios
Enterprise value
—
180.65 M
616.57 M
179.4 M
157.03 M
936.43 M
2.07 B
Price to earnings ratio
—
—
-13.81
-4.42
-4.03
-12.74
-30.9
Price to sales ratio
—
—
7 738.68
—
234.36
—
—
Price to cash flow ratio
—
—
-15.87
-4.63
-4.44
-17.23
-42.3
Price to book ratio
—
—
2.98
1.27
1.59
4.3
6.54
Enterprise value to EBITDA ratio
—
-2.17
-15.12
-3.61
-2.8
-12.91
-29.64
Profitability ratios
Return on assets %
-0.57
-0.53
-0.2
-0.27
-0.35
-0.3
-0.43
Return on equity %
-0.74
-0.59
-0.22
-0.29
-0.39
-0.34
-0.51
Return on invested capital %
-2 400.42
-3 895.2
-2 451.74
-3 972.63
-3 718.91
-3 106.31
—
Gross margin %
100
100
100
—
100
—
—
Operating margin %
9 932.86
-194.96 K
-59.51 K
—
-6 661.76
—
—
EBITDA margin %
9 175.71
-193.43 K
-58.26 K
—
-6 591.18
—
—
Net margin %
10.54 K
-195.67 K
-56.04 K
—
-5 808.82
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.97
13.84
12.05
19.73
14.96
15.02
48.83
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0.01
0
0
0
0.01
0
0
Solvency ratios
Debt to assets ratio
0.04
0.03
—
—
—
—
—
Debt to equity ratio
0.05
0.03
—
—
—
—
—
Long term debt to total assets ratio
0.04
0
—
—
—
—
—
Long term debt to total equity ratio
0.05
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-0.32
-0.32
-0.33
-0.31
-0.33
EBIT per share
—
—
-0.4
-0.4
-0.41
-0.46
-0.49
EBITDA per share
—
—
-0.39
-0.39
-0.41
-0.46
-0.49
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.77
1.2
0.92
1.32
4.17
Net current asset value per share
—
—
1.85
1.21
0.97
1.33
4.31
Tangible book value per share
—
—
1.73
1.17
0.91
1.25
3.96
Working capital per share
—
—
1.7
1.15
0.9
1.24
3.94
Book value per share
—
—
1.73
1.17
0.91
1.25
3.96
News
Will Psychedelic Stocks Have A Trippy Ride Under RFK Jr.?
Compass Therapeutics stock rating reaffirmed at Citizens on trial progress
Jefferies raises Compass Therapeutics stock price target on trial progress
Compass Therapeutics stock holds Outperform at William Blair ahead of trial data
Raymond James reiterates Compass Therapeutics stock Outperform rating
Compass Therapeutics earnings on deck as pivotal cancer data looms
Is Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year?
Craig-Hallum initiates coverage on Compass Therapeutics stock with Buy rating
Compass Therapeutics stock rises after Craig-Hallum initiates coverage with Buy
Canaccord Genuity raises Compass Therapeutics stock price target on Phase 2/3 data expectations
Compass Therapeutics stock hits 52-week high at 6.51 USD
Are Medical Stocks Lagging ResMed (RMD) This Year?